{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:56:25Z","timestamp":1789214185702,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.062","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T13:48:56Z","timestamp":1396273736000},"page":"3010-3018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4"],"prefix":"10.1016","volume":"32","author":[{"given":"Gregory D.","family":"Gromowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Yen","family":"Firestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.062_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell host & microbe"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.03.062_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0245","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"Journal of virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0250","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.vaccine.2010.12.108","article-title":"Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0255","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.03.062_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00041-4","article-title":"Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains","volume":"18","author":"Kurane","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.062_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","article-title":"Current use and development of vaccines for Japanese encephalitis","volume":"8","author":"Beasley","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2014.03.062_bib0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(00)00039-6","article-title":"Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus","volume":"18","author":"Tsarev","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0265","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0055","first-page":"171","article-title":"Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections","volume":"267","author":"Solomon","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"van den Hurk","year":"2009","journal-title":"Annu Rev Entomol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.062_bib0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2014.03.062_bib0070","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1517\/14712598.2012.704908","article-title":"Clinical development of IMOJEV (R)\u2014a recombinant Japanese encephalitis chimeric vaccine (JE-CV)","volume":"12","author":"Appaiahgari","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0075","first-page":"2","article-title":"Japanese Encephalitis Vaccines","volume":"S1","author":"McArthur","year":"2011","journal-title":"J Bioterror Biodef"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0270","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2014.03.062_bib0085","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"issue":"9611","key":"10.1016\/j.vaccine.2014.03.062_bib0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.062_bib0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0275","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jis936","article-title":"A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial","volume":"207","author":"Durbin","year":"2013","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0280","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0285","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.vaccine.2008.05.075","article-title":"Evaluation of St. Louis encephalitis virus\/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys","volume":"26","author":"Blaney","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0290","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0295","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/S0264-410X(03)00488-2","article-title":"Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys","volume":"21","author":"Whitehead","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4142\/jvs.2012.13.2.111","article-title":"Isolation and genetic characterization of Japanese encephalitis virus from equines in India","volume":"13","author":"Gulati","year":"2012","journal-title":"Journal of veterinary science"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.062_bib0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2001.65.242","article-title":"Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent","volume":"65","author":"Uchil","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0305","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12275-012-2336-6","article-title":"Biological and genetic properties of SA(1)(4)-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans","volume":"50","author":"Song","year":"2012","journal-title":"Journal of microbiology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2019-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.062_bib0150","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hygiene"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell host & microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2014.03.062_bib0165","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0325","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"Journal of virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0330","article-title":"A novel cis-acting element within the capsid-coding region enhances flavivirus vRNA replication by regulating genome cyclization","author":"Liu","year":"2013","journal-title":"Journal of virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0335","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.virol.2011.10.025","article-title":"Composition of the sequence downstream of the dengue virus 5\u2019 cyclization sequence (dCS) affects viral RNA replication","volume":"422","author":"Friebe","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0340","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JVI.05431-11","article-title":"Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation","volume":"86","author":"Samsa","year":"2012","journal-title":"Journal of virology"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2014.03.062_bib0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF01718326","article-title":"RNA binding properties of core protein of the flavivirus Kunjin","volume":"141","author":"Khromykh","year":"1996","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0345","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.febslet.2011.06.038","article-title":"RNA binding property and RNA chaperone activity of dengue virus core protein and other viral RNA-interacting proteins","volume":"585","author":"Pong","year":"2011","journal-title":"FEBS letters"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.062_bib0200","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JVI.72.3.2141-2149.1998","article-title":"Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM","volume":"72","author":"Stocks","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.062_bib0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JVI.74.1.24-32.2000","article-title":"Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production","volume":"74","author":"Lee","year":"2000","journal-title":"Journal of virology"},{"issue":"10","key":"10.1016\/j.vaccine.2014.03.062_bib0215","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0355","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0360","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0042-6822(03)00197-1","article-title":"A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4","volume":"312","author":"Hanley","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0365","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.70.6.3930-3937.1996","article-title":"Dengue type 4 virus mutants containing deletions in the 3\u2019 noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys","volume":"70","author":"Men","year":"1996","journal-title":"Journal of virology"},{"key":"10.1016\/j.vaccine.2014.03.062_bib0370","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"Journal of virology"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.062_bib0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1083\/jcb.200806081","article-title":"Identification of specific histidines as pH sensors in flavivirus membrane fusion","volume":"183","author":"Fritz","year":"2008","journal-title":"J Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T01:49:21Z","timestamp":1597628961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":48,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004319"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}